Education and Expertise
Dr. Daniel Labow earned his medical degree from Warren Alpert Medical School at Brown University. He completed his general surgery residency at the University of Chicago and his surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center.
He currently practices as a surgical oncologist at Mount Sinai Morningside and Mount Sinai West Hospitals, where he also serves as Program Director for the Surgical Oncology Fellowship, as well as Vice-Chair of Outpatient Services and Chair of the Department of Surgery. Dr. Labow also established and directs one of the highest-volume hyperthermic intraperitoneal chemotherapy (HIPEC) centers in the country.
Dr. Daniel Labow established and directs one of the highest-volume hyperthermic intraperitoneal chemotherapy (HIPEC) centers in the country.
Dr. Labow is specialized in treating peritoneal mesothelioma with HIPEC. HIPEC is preceded by cytoreductive surgery to remove all visible tumors from the abdominal lining. HIPEC then bathes the abdominal organs in chemotherapy, killing any residual microscopic tumors. Dr. Labow performs HIPEC because, in comparison to intravenous chemotherapy, it generally has fewer side effects, is more effective, and can significantly improve an individual’s prognosis.
Dr. Labow also performs minimally invasive robotic surgery to treat mesothelioma. He prefers this technique over more aggressive surgical techniques because it has fewer risks, is less invasive, and has a shorter recovery time.
When facing a diagnosis of mesothelioma, it is crucial to find the right treatment, right away. Contact Dr. Daniel Labow today.